Amjevita 72511-0481

Generic: Adalimumab-Atto

Product NDC

72511-0481

Manufacturer: Amgen Usa Inc.
Dosage Form: Injection
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: August 14, 2023
Listing Expires: December 31, 2026
Application: BLA761024

Need to source Amjevita? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Adalimumab	80 mg/.8mL

Drug Class

Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]

Packaging Options(1)

72511-0481-02

2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE

View →